PrEP Becoming More Widely Accepted As HIV Prevention Strategy, Financial Times Reports

Financial Times: Pre-exposure drug is new HIV front line
“…A growing body of evidence shows that large numbers of people at risk of contracting the virus should be on medication as a preventive measure. Pre-exposure prophylaxis, or PrEP, is a strategy where patients take a once-a-day pill to reduce their risk of acquiring the virus…” (Crow, 12/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.